Masimo Corporation agreed to be acquired by Danaher for $180/share, valuing MASI at $9.9B. Click here to read my most recent ...
Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient ...
Danaher stock fell after the company announced a $9.9B all-cash deal to buy Masimo, expanding its diagnostics and patient monitoring business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results